The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Pharmacology

• Publication date

  2009-12-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2009.09.048PMID 19818342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes.

  2009cited by this paper
• Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes

  2008cited by this paper
• Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.

  2008cited by this paper
• Endoplasmic reticulum stress in beta cells: latent mechanism of secondary sulfonylurea failure in type 2 diabetes?

  2008cited by this paper
• Glucose metabolism and hyperglycemia.

  2008cited by this paper
• Effects of miglitol, an α-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats

  2007cited by this paper
• Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.

  2007cited by this paper
• Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.

  2006cited by this paper
• Effect of inhibition of alpha-glucosidase on age-related glucose intolerance and pancreatic atrophy in rats.

  2006cited by this paper
• Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors

  2006cited by this paper
• Sulfonylurea Induced β-Cell Apoptosis in Cultured Human Islets

  2005cited by this paper
• The Hyperglycemia-induced Inflammatory Response in Adipocytes

  2005cited by this paper
• Programmed disorders of β‐cell development and function as one cause for type 2 diabetes? The GK rat paradigm

  2005cited by this paper
• Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy

  2004cited by this paper
• Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.

  2004cited by this paper
• Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

  2002cited by this paper
• Insulin and glucagon secretions, and morphological change of pancreatic islets in OLETF rats, a model of type 2 diabetes mellitus.

  2002cited by this paper
• Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

  2002cited by this paper
• Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor

  2000cited by this paper
• Inhibition of progressive reduction of islet beta-cell mass in spontaneously diabetic Goto-Kakizaki rats by alpha-glucosidase inhibitor.

  2000cited by this paper
• Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).

  1999cited by this paper
• Effect of miglitol administration to non-insulin-dependent diabetic rats.

  1998cited by this paper
• Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus.

  1998cited by this paper
• Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats).

  1994cited by this paper
• AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet.

  1993cited by this paper
• Metabolic consequences of the alpha-glucosidase inhibitor BAY-M-1099 given to nondiabetic and diabetic rats fed a high-carbohydrate diet.

  1989cited by this paper
• Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.

  1988cited by this paper
• Inhibitory mechanism of acarbose and 1-deoxynojirimycin derivatives on carbohydrases in rat small intestine.

  1987cited by this paper
• Inhibitors of the rate of carbohydrate and lipid absorption by the intestine.

  1984cited by this paper

• A versatile and automatic on-line screening method: Transverse diffusion of laminar flow profiles-based capillary electrophoresis for exploring PTP1B inhibitors in natural products.

  2024cites this paper
• New Horizons in Diabetic Neuropathies: An Updated Review on their Pathology, Diagnosis, Mechanism, Screening Techniques, Pharmacological, and Future Approaches.

  2023cites this paper
• Dithiocarbamates as potential PTP1B inhibitors for diabetes management

  2022cites this paper
• Type 2 Diabetes Mellitus: Pathogenic Features and Experimental Models in Rodents

  2022cites this paper
• Development of the Diabetic Kidney Disease Mouse Model Culturing Embryos in α-Minimum Essential Medium In Vitro, and Feeding Barley Diet Attenuated the Pathology

  2021cites this paper
• PTP1B Inhibitors as Potential Target for Type II Diabetes

  2020cites this paper
• Mechanism of non-enzymatic antiglycation action by coumarin: a biophysical study

  2019cites this paper
• Hydroxyl Groups in Synthetic and Natural-Product-Derived Therapeutics: A Perspective on a Common Functional Group.

  2019cites this paper
• SGLT1 inhibition boon or bane for diabetes‐associated cardiomyopathy

  2019cites this paper
• Screening for Biologically Annotated Drugs That Trigger Triacylglycerol Accumulation in the Diatom Phaeodactylum1

  2018cites this paper
• Study of pyridoxamine against glycation and reactive oxygen species production in human serum albumin as model protein: An in vitro & ex vivo approach.

  2018cites this paper
• Insulin‐Stimulated Bone Blood Flow and Bone Biomechanical Properties Are Compromised in Obese, Type 2 Diabetic OLETF Rats

  2017cites this paper
• 1-Deoxynojirimycin: Sources, Extraction, Analysis and Biological Functions

  2017cites this paper
• Potential Dual Role of Eugenol in Inhibiting Advanced Glycation End Products in Diabetes: Proteomic and Mechanistic Insights

  2016cites this paper
• Molecular docking simulation of mangostin derivatives and curcuminoid on maltase- glucoamylase target for searching anti-diabetes drug candidates

  2016cites this paper
• Pancreatic regulation of glucose homeostasis

  2016cites this paper
• Treatment with DPP-4I Anagliptin or α-GI Miglitol Reduces IGT Development and the Expression of CVD Risk Factors in OLETF Rats.

  2015cites this paper
• 1-deoxynojirimycin isolated from Bacillus subtilis improves hepatic lipid metabolism and mitochondrial function in high-fat-fed mice.

  2015cites this paper
• Antioxidant and hypoglycaemic effects of local bitter gourd fruit (Momordica charantia)

  2015cites this paper
• Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis.

  2014cites this paper
• Applications of Molecular Modeling in Endocrinology- Review Article

  2014cites this paper
• The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.

  2013cites this paper
• Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.

  2013cites this paper
• KGA-2727, a Novel Selective Inhibitor of a High-Affinity Sodium Glucose Cotransporter (SGLT1), Exhibits Antidiabetic Efficacy in Rodent Models

  2012cites this paper
• Protein Tyrosine Phosphatase 1B Inhibitors: A Molecular Level Legitimate Approach for the Management of Diabetes Mellitus

  2012cites this paper
• The use of animal models in diabetes research

  2012cites this paper
• Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.

  2011cites this paper
• Differential vulnerability of skeletal muscle feed arteries to dysfunction in insulin resistance: impact of fiber type and daily activity.

  2011cites this paper
• Synergistic effect of α‐glucosidase inhibitors and dipeptidyl peptidase 4 inhibitor treatment

  2010cites this paper
• Changes in α-glucosidase activities along the jejunal-ileal axis of normal rats by the α-glucosidase inhibitor miglitol.

  2010cites this paper
• Reduced Expression of β2 Integrin Genes in Rat Peripheral Leukocytes by Inhibiting Postprandial Hyperglycemia

  2010cites this paper